Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 2
2010 3
2011 4
2014 1
2015 4
2016 5
2017 6
2018 9
2019 5
2020 9
2021 8
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ; OlympiA Clinical Trial Steering Committee and Investigators. Geyer CE Jr, et al. Ann Oncol. 2022 Dec;33(12):1250-1268. doi: 10.1016/j.annonc.2022.09.159. Epub 2022 Oct 10. Ann Oncol. 2022. PMID: 36228963 Free PMC article. Clinical Trial.
COX-1 dependent biosynthesis of 15-hydroxyeicosatetraenoic acid in human mast cells.
Johnsson AK, Rönnberg E, Fuchs D, Kolmert J, Säfholm J, Claesson HE, Hamberg M, Wheelock CE, Nilsson G, Dahlén SE. Johnsson AK, et al. Among authors: fuchs d. Biochim Biophys Acta Mol Cell Biol Lipids. 2021 May;1866(5):158886. doi: 10.1016/j.bbalip.2021.158886. Epub 2021 Jan 13. Biochim Biophys Acta Mol Cell Biol Lipids. 2021. PMID: 33450390
Savage War Injuries: the Alleviation of Suffering.
Solomonov E, Braslavsky A, Fuchs D, Biswas S. Solomonov E, et al. Among authors: fuchs d. Isr Med Assoc J. 2017 Mar;19(3):137-138. Isr Med Assoc J. 2017. PMID: 28457087 Free article. No abstract available.
Electrochemical Behavior of Graphene in a Deep Eutectic Solvent.
Fuchs D, Bayer BC, Gupta T, Szabo GL, Wilhelm RA, Eder D, Meyer JC, Steiner S, Gollas B. Fuchs D, et al. ACS Appl Mater Interfaces. 2020 Sep 9;12(36):40937-40948. doi: 10.1021/acsami.0c11467. Epub 2020 Aug 26. ACS Appl Mater Interfaces. 2020. PMID: 32805835 Free PMC article.
53 results